Creon 6000 [USP'U]/1

Creon 6000 is a prescription medication containing pancrelipase, an enzyme replacement therapy. It is used to treat people who cannot digest food normally due to conditions such as cystic fibrosis, pancreatitis, or pancreatic surgery. The medication works by replacing the enzymes normally produced by the pancreas, allowing for proper digestion and absorption of nutrients. Creon 6000 is available in a delayed-release capsule form.

Creon 6000 is used to treat malabsorption due to pancreatic insufficiency. This condition can occur in individuals with cystic fibrosis, chronic pancreatitis, or those who have undergone pancreatic surgery. The medication helps to replace the missing pancreatic enzymes, allowing for the proper digestion of food and absorption of essential nutrients.

Common side effects of Creon 6000 include abdominal pain, diarrhea, and nausea. In some cases, patients may experience allergic reactions, such as hives, itching, or difficulty breathing. It is essential to follow the prescribed dosage and administration instructions to minimize the risk of adverse effects.

Creon 6000 should be stored at room temperature, away from moisture and heat. The capsules should not be crushed or chewed, as this can cause the medication to be released too quickly. Patients should follow the prescribed dosage and administration instructions carefully to ensure safe and effective use of the medication.

Creon 6000 may interact with other medications, such as antacids or acid-reducing agents. Patients should inform their healthcare provider about all medications they are taking, including supplements and vitamins, to minimize the risk of interactions.